SEMA7A and glioma: More recently, SEMA7A has been reported to be a protumor factor that promotes the progression of multiple cancers, such as melanoma (17), oral cancer (18), breast cancer (30) and glioma (31) by promoting the proliferation, invasion and migration of tumor cells as well as the epithelial-to-mesenchymal transition.